HealthEquity (NASDAQ:HQY) Reaches New 1-Year High – Still a Buy?

HealthEquity, Inc. (NASDAQ:HQY) shares reached a new 52-week high during trading on Monday . The stock traded as high as $105.82 and last traded at $104.41, with a volume of 109861 shares. The stock had previously closed at $104.25.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on HQY shares. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. BTIG Research lifted their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft increased their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Barrington Research restated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. Finally, The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective on the stock. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $107.23.

HealthEquity Stock Down 1.1 %

The company’s 50-day moving average is $88.75 and its 200 day moving average is $82.32. The stock has a market capitalization of $8.95 billion, a PE ratio of 86.18, a price-to-earnings-growth ratio of 1.62 and a beta of 0.52. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The business had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. As a group, analysts anticipate that HealthEquity, Inc. will post 2.27 EPS for the current year.

Insider Buying and Selling at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now owns 3,784 shares in the company, valued at $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,536 shares of company stock worth $884,517. Company insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. International Assets Investment Management LLC acquired a new position in shares of HealthEquity during the second quarter valued at approximately $35,000. Paladin Wealth LLC purchased a new stake in shares of HealthEquity during the third quarter worth approximately $39,000. GAMMA Investing LLC lifted its holdings in HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after purchasing an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in HealthEquity during the 2nd quarter worth $73,000. Finally, Quarry LP grew its holdings in shares of HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after buying an additional 1,089 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.